Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-23 Purchase |
2022-05-24 4:47 pm |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer |
20,000 | $0.84 | $16,800 | 20,600 (Direct) |
View |
| 2022-05-17 Purchase |
2022-05-19 7:43 pm |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
10,000 | $0.8228 | $8,228 | 10,000 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-18 4:43 pm |
Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director |
30,000 | $0.8526 | $25,578 | 50,000 (Direct) |
View |
| 2022-05-13 Purchase |
2022-05-17 6:28 pm |
Adverum Biotechnologies Inc. | ADVM | D'Souza Rupert Chief Financial Officer |
20,000 | $0.84285 | $16,857 | 20,850 (Direct) |
View |
| 2022-04-20 Purchase |
2022-04-22 5:00 pm |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
25,000 | $1.112 | $27,800 | 762,462 (Direct) |
View |
| 2022-04-19 Purchase |
2022-04-20 4:35 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
21,925 | $1.14 | $24,994 | 280,556 (Direct) |
View |
| 2021-12-08 Purchase |
2021-12-10 5:26 pm |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
25,000 | $1.8244 | $45,609 | 737,462 (Direct) |
View |
| 2021-12-08 Purchase |
2021-12-10 5:26 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
25,000 | $1.91 | $47,750 | 258,631 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-17 4:38 pm |
Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director |
50,000 | $2.18 | $109,000 | 3,334 (Indirect) |
View |
| 2021-09-30 Sale |
2021-10-04 5:36 pm |
Adverum Biotechnologies Inc. | ADVM | Clark Julie Chief Medical Officer |
4,766 | $2.17 | $10,342 | 164,723 (Direct) |
View |
| 2021-03-31 Purchase |
2021-04-01 8:21 pm |
Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director |
20,000 | $10.02 | $200,338 | 20,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-17 Option Award |
2022-03-18 5:15 pm |
N/A 2032-03-16 |
Adverum Biotechnologies Inc. | ADVM | Hong Soo Director |
80,000 | $0 | 80,000 (Direct) |
View |
Ownership |
2022-03-18 5:14 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Hong Soo Director |
0 | $0 | 0 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:12 pm |
N/A 2032-03-16 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director |
80,000 | $0 | 80,000 (Direct) |
View |
Ownership |
2022-03-18 5:11 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director |
0 | $0 | 0 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-17 4:53 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer |
195,000 | $0 | 195,000 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-17 4:51 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
255,000 | $0 | 255,000 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-17 4:50 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
630,000 | $0 | 630,000 (Direct) |
View |
| 2022-02-07 Option Award |
2022-02-09 5:10 pm |
N/A 2032-02-06 |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
485,000 | $0 | 485,000 (Direct) |
View |
Ownership |
2022-02-09 5:08 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 5:04 pm |
N/A 2032-01-05 |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer |
425,000 | $0 | 425,000 (Direct) |
View |
Ownership |
2022-01-10 5:02 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer |
0 | $0 | 600 (Direct) |
View |
| 2021-12-06 Option Award |
2021-12-08 5:26 pm |
N/A 2031-12-05 |
Adverum Biotechnologies Inc. | ADVM | D'Souza Rupert Chief Financial Officer |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-12-08 5:24 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | D'Souza Rupert Chief Financial Officer |
0 | $0 | 850 (Direct) |
View |
Ownership |
2021-09-14 4:50 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer |
0 | $0 | 610,000 (Direct) |
View |
Ownership |
2021-09-13 5:49 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | THRIFT JACK ANTHONY Interim CFO |
0 | $0 | 0 (Direct) |
View |
| 2021-08-06 Option Award |
2021-08-10 9:26 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Clark Julie Chief Medical Officer |
120,000 | $0 | 169,489 (Direct) |
View |
| 2021-08-06 Option Award |
2021-08-10 9:25 pm |
N/A 2031-08-05 |
Adverum Biotechnologies Inc. | ADVM | Thedinga Angela Chief Technology Officer |
270,000 | $0 | 270,000 (Direct) |
View |
| 2021-08-06 Option Award |
2021-08-10 9:24 pm |
N/A 2031-08-05 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
380,000 | $0 | 390,692 (Direct) |
View |
| 2021-08-06 Option Award |
2021-08-10 9:23 pm |
N/A 2031-08-05 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
1,135,000 | $0 | 1,161,292 (Direct) |
View |
Ownership |
2021-06-29 6:53 pm |
N/A 2031-02-17 |
Adverum Biotechnologies Inc. | ADVM | DeRespino Christopher See Remarks |
0 | $0 | 425,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 6:57 pm |
N/A 2031-05-31 |
Adverum Biotechnologies Inc. | ADVM | Clark Julie Chief Medical Officer |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-06-03 6:55 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Clark Julie Chief Medical Officer |
0 | $0 | 143,239 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-14 8:05 pm |
N/A 2031-05-11 |
Adverum Biotechnologies Inc. | ADVM | Woiwode Thomas Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-14 8:04 pm |
N/A 2031-05-11 |
Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-14 8:04 pm |
N/A 2031-05-11 |
Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-14 8:03 pm |
N/A 2031-05-11 |
Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-14 8:02 pm |
N/A 2031-05-11 |
Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-14 8:01 pm |
N/A 2031-05-11 |
Adverum Biotechnologies Inc. | ADVM | Gasmi Mehdi Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-14 8:01 pm |
N/A 2031-05-11 |
Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director |
52,500 | $0 | 52,500 (Direct) |
View |